In a first, this week the U.S. Food and Drug Administration approved a brain stimulation device designed to treat depression at home. The approval of the first such device for home depression ...
PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ — EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...
The MarketWatch News Department was not involved in the creation of this content. PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD(R) , a global leader in Closed System Transfer Devices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback